The American Cancer Society (ACS) and Flatiron Health has announced the launch of the American Cancer Society & Flatiron Health Real-World Data Impact Award. This joint grant-making program supports both organizations’ goals of accelerating cancer research and improving treatment and care options for patients.
The ACS and Flatiron designed the program to advance patient-centric research among investigators currently funded by the ACS. Up to three grants in the amount of $75,000 each will be awarded during 2020 to existing ACS grantees with experience in health services or observational research. The ACS will oversee the grant selection process, and Flatiron will provide selected grantees with research funding and access to its de-identified oncology data sets curated from electronic health records for research purposes.
Research Possibilities
Research may include characterizing health-care disparities in treatment and outcomes among underserved populations in the United States; evaluating national health-care policy impact on practice patterns and patient outcomes; comparing the effectiveness of treatments unlikely to be addressed by clinical trials; and assessing the impact of clinical guidelines on treatment and outcomes.
Eligible grantees have been sent individual communication about this funding opportunity. A letter of intent process will be used to invite applications for the April 15, 2020, deadline. Current ACS grantees may contact grants.eligibility@cancer.org for more details. ■
